AMTB vs BBDC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMTB presents a stark contrast between attractive valuation and deteriorating fundamental health. While the stock trades below its Graham Number ($27.18) and Intrinsic Value ($41.89), the Piotroski F-Score of 2/9 indicates significant weakness in financial health. Strong year-over-year earnings growth (57.10%) is offset by sluggish revenue growth (3.30%) and a highly bearish technical trend (10/100). The company is essentially trading at book value (P/B 0.99), making it a value play with high fundamental risk.
The Advanced Deterministic Scorecard reveals significant concerns, with a Piotroski F-Score of just 2/9 indicating weak financial health. Despite a high dividend yield of 11.27%, the unsustainable 108.33% payout ratio and bearish insider activity raise red flags. While profitability metrics like operating margin and ROE are strong relative to peers, elevated debt (D/E of 1.39) and deteriorating earnings momentum in recent quarters undermine confidence. The stock trades below intrinsic value estimates ($17.34) and slightly above the Graham Number ($15.40), but structural risks outweigh valuation appeal.
Compare Another Pair
Related Comparisons
AMTB vs BBDC: Head-to-Head Comparison
This page compares Amerant Bancorp Inc. (AMTB) and Barings BDC, Inc. (BBDC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.